argenx announced that during the extraordinary general meeting of shareholders Mrs. Camilla Sylvest was appointed as non-executive director to its Board of Directors. Mrs. Sylvest brings strong strategic and operational leadership in the scaling of global commercial pharmaceutical organizations with a specific focus on company culture and sustainability.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
352 EUR | -1.01% | +0.03% | +2.42% |
17/06 | Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating | MT |
13/06 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.42% | 22.66B | |
+16.91% | 122B | |
+19.11% | 113B | |
-16.77% | 21.34B | |
-39.57% | 16.92B | |
-14.17% | 16.68B | |
-16.31% | 16.61B | |
+2.72% | 13.62B | |
+21.30% | 11.04B | |
+108.71% | 10.43B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx Appoints Camilla Sylvest to Board of Directors